Increased lipid peroxidation in patients with rhabdomyolysis

Lancet

Volumn 353, Issue 9160, 1999, Pages 1241-

  Holt, Steve ^a   Reeder, Brandon ^b   Wilson, Mike ^b   Harvey, Sheila ^b   Morrow, Jason D ^b   Roberts II, L Jackson ^b   Moore, Kevin ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; LIPID PEROXIDATION; PRIORITY JOURNAL; RHABDOMYOLYSIS;

EID: 0344937960     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)05768-7     Document Type: Article

References (5)

1. Moore KP, Holt SG, Patel RP, et al. A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure. J Biol Chem 1998; 273: 31731-37.
2. Zager RA. Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int 1996; 49: 314-26.
3. Moore K, Roberts LJ. Measurement of lipid peroxidation. Free Radic Res 1998; 28: 659-71.
4. Catalano CE, Choe YS, Ortiz de Montellano PR. Reactions of the protein radical in per oxide-treated myoglobin. Formation of a hemeprotein cross-link. J Biol Chem 1989; 264: 10534-41.
5. Salahudeen AK, Wang C, Bigler SA, Dai Z, Tachikawa H. Synergistic renal protection by combining alkaline-diuresis with lipid peroxidation inhibitors in rhabdomyolysis: possible interaction between oxidant and non-oxidant mechanisms. Neurol Dial Transplant 1996; 11: 635-42.